IP Library Assignment 033372/0549
Patent Assignment
Reel/Frame 033372/0549

Assignment of Assignor's Interest

Recorded: 2014-07-23 Pages: 4
Assignor
SERENITY PHARMACEUTICALS LLC
Executed: 2014-04-01
Assignee
ALLERGAN, INC.
2525 DUPONT DRIVE, IRVINE, CALIFORNIA, 92612
Covered Property (1)
Methods and Compositions Comprising Desmopressin in Combination with a 5-Alpha Reductase Inhibitor
Patent: 9,925,232 →
Application: 14/338,567 →
Publication: US 2015/0031614
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 19, 2017
From: ALLERGAN, INC.
To: SERENITY PHARMACEUTICALS LLC
Reel/Frame 042747/0283 →
Assignment of Assignor's Interest Jun 21, 2017
From: FEIN, SEYMOUR H.; CHENG, LINDA; CHENG, MARIA; HERSCHKOWITZ, SAMUEL
To: SERENITY PHARMACEUTICALS LLC
Reel/Frame 042774/0024 →
Change of Name Sep 22, 2022
From: SERENITY PHARMACEUTICALS LLC
To: ACERUS PHARMACEUTICALS USA, LLC
Reel/Frame 061509/0419 →
Security Interest Dec 22, 2022
From: ACERUS PHARMACEUTICALS USA, LLC
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 062185/0506 →
Security Interest Dec 22, 2023
From: ACERUS PHARMACEUTICALS USA, LLC
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 065943/0612 →